Cardio IQ® Diabetes Risk Panel with Score

Cardio IQ® Diabetes Risk Panel with Score

Test Code

92026
80061, 82947, 83036
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
92026
80061, 82947, 83036
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Not offered in Quest Nichols Institute - Chantilly, VA | Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano | Quest Nichols Institute -San Juan Capistrano, CA. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.

Clinical Significance

Cardio IQ® Diabetes Risk Panel with Score - To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Test Resources

None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.

Test Details

Includes

  • Cardio IQ® Glucose
  • Cardio IQ® Hemoglobin A1c
  • Cardio IQ® Cholesterol, Total
  • Cardio IQ® HDL Cholesterol
  • Cardio IQ® Triglycerides
  • Cardio IQ® Non-HDL and Calculated Components
  • Cardio IQ® 8 Year Diabetes Risk
  •  
  • If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).

Patient Preparation

If a cholesterol measurement is to be performed along with Triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.

Methodology

Turbidimetric Inhibition Immunoassay • Spectrophotometry (SP)

Reference Range(s)

See individual tests

Alternative Name(s)

CardioIQ®,Diabetes Risk Panel with Score, Cardio IQ®

LOINC® Codes, Performing Laboratory

Service Area must be determined
Cardio IQ® Glucose
Cardio IQ® Hemoglobin A1c
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® 8 Year Diabetes Risk

If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
If a cholesterol measurement is to be performed along with Triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.

Methodology

Turbidimetric Inhibition Immunoassay • Spectrophotometry (SP)

Reference Range(s)

See individual tests

Alternative Name(s)

CardioIQ®,Diabetes Risk Panel with Score, Cardio IQ®
Service Area must be determined

Preferred Specimen(s)

4 mL serum collected in a Serum separator tube (SST) and 1 mL whole blood collected in an EDTA (lavender-top) tube

Minimum Volume

2 mL serum • 0.5 mL whole blood

Collection Instructions

For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)

Transport Container

Serum separator tube (SST) and EDTA (lavender-top) tube

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Serum
  • Room temperature: 48 hours
  • Refrigerated: 5 days
  • Frozen: 15 days
  •  
  • Whole blood
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: 6 months

Reject Criteria

Gross hemolysis • Red-top tube (no gel) • Moderate to grossly icteric

Setup Schedule

Service Area must be determined
4 mL serum collected in a Serum separator tube (SST) and 1 mL whole blood collected in an EDTA (lavender-top) tube
2 mL serum • 0.5 mL whole blood
For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)
Serum separator tube (SST) and EDTA (lavender-top) tube
Refrigerated (cold packs)
Serum
Room temperature: 48 hours
Refrigerated: 5 days
Frozen: 15 days

Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months
Gross hemolysis • Red-top tube (no gel) • Moderate to grossly icteric
Service Area must be determined
Not offered in Quest Nichols Institute - Chantilly, VA | Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano | Quest Nichols Institute -San Juan Capistrano, CA. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.

Customize the test information for your Service Area